SCHEMBL23618375

SCHEMBL23618375

Fc1ccc(-n2c3ccccc3c3c4c(c5ccccc5n4-c4ccccc4)c4c(c5ccccc5n4-c4ccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)cc4)c32)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.42
ABCG2 Q9UNQ0 1/20 0.42
GRIA1 P42261 1/20 0.41
CACNG8 Q8WXS5 1/20 0.41
CACNG2 Q9Y698 1/20 0.41
KDM4E B2RXH2 3/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NPC1 O15118 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
HKDC1 Q2TB90 2/20 0.39
KMT2A Q03164 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
LMNA P02545 3/20 0.39
MAPT P10636 3/20 0.39
MEN1 O00255 1/20 0.39
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23618371 0.99 NR3C1 (0.43) NR3C1ABCG2GRIA1CACNG8CACNG2
SCHEMBL20385225 0.93 L3MBTL1 (0.47) ABCG2KDM4EATML3MBTL1NPC1
SCHEMBL20385282 0.93 L3MBTL1 (0.47) ABCG2KDM4EATML3MBTL1NPC1
SCHEMBL23618379 0.93 ABCG2 (0.42) NR3C1ABCG2GRIA1CACNG8CACNG2
SCHEMBL26923778 0.92 NPSR1 (0.49) NR3C1ABCG2GRIA1CACNG8CACNG2
SCHEMBL20385320 0.92 L3MBTL1 (0.46) ABCG2KDM4EATML3MBTL1NPC1
SCHEMBL20385284 0.92 L3MBTL1 (0.44) ABCG2KDM4EATML3MBTL1KMT2A
SCHEMBL30168531 0.92 L3MBTL1 (0.44) ABCG2KDM4EATML3MBTL1KMT2A
SCHEMBL23618400 0.90 NPSR1 (0.46) NR3C1ABCG2GRIA1CACNG8CACNG2
SCHEMBL23618378 0.90 ABCG2 (0.41) NR3C1ABCG2KDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11844272-B2 Organic electroluminescence device and polycyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-12-12 US disclosed
US-11844272-B2 Organic electroluminescence device and polycyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-12-12 US disclosed
US-20210210695-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2021-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210210695-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE PIEZO1, LEF1, ODC1 NR3C1 2471/4885ABCG2 4119/4885GRIA1 752/4885
US-11844272-B2 Organic electroluminescence device and polycyclic compound for organic electroluminescence device PIEZO1, LEF1, ODC1 NR3C1 2471/4885ABCG2 4119/4885GRIA1 752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.